Patients With Pulmonary Disease Shouldn ' t Quit Aerosolized Medication Over COVID Fears Patients With Pulmonary Disease Shouldn ' t Quit Aerosolized Medication Over COVID Fears

COVID-19 concerns should not stop patients from using inhaled corticosteroids, a new commentary article suggests.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news